# Nuclide record pluvicto (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/pluvicto/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "pluvicto" ;
  schema:name "Lutetium-177 vipivotide tetraxetan"@en ;
  schema:description "A radioactive drug that seeks out PSMA on prostate cancer cells; the best-selling radiopharmaceutical ever."@en ;
  schema:url <https://nuclide.cc/drugs/pluvicto/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Lutetium_(177Lu)_vipivotide_tetraxetan> ;
  owl:sameAs <http://www.wikidata.org/entity/Q111353661> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lutetium-177%20vipivotide%20tetraxetan> ;
  nuclide:status "approved" ;
  nuclide:modality "Radioligand therapy (beta)" ;
  schema:alternateName "Pluvicto" ;
  nuclide:approval "US 2022: PSMA+ mCRPC after ARPI and taxane", "US 2025: PSMA+ mCRPC after ARPI, before chemotherapy", "US 2026: Label expansion (July 2026)", "EU 2022: mCRPC post-ARPI and taxane; pre-chemo 2025" ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/indications/prostate-mcrpc/>, <https://nuclide.cc/indications/prostate-mhspc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/radioligand-therapy/>, <https://nuclide.cc/technologies/psma-pet/> ;
  nuclide:targets <https://nuclide.cc/targets/psma/> ;
  nuclide:companies <https://nuclide.cc/companies/novartis/> ;
  nuclide:trials <https://nuclide.cc/trials/vision/>, <https://nuclide.cc/trials/psmafore/>, <https://nuclide.cc/trials/nct05682443/>, <https://nuclide.cc/trials/nct06894511/>, <https://nuclide.cc/trials/nct06004661/> ;
  nuclide:people <https://nuclide.cc/people/louise-emmett/> .